Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/bf/b0/a0/bfb0a050-9d15-b843-3b2a-ab8a774382fc/mza_17908578731465340111.jpg/600x600bb.jpg

Small Stocks, Big Money

RedChip Companies

113 episodes

2 days ago

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

Business

RSS

All content for Small Stocks, Big Money is the property of RedChip Companies and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/38420737/38420737-1689948917073-c156b20bb02fe.jpg

Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe

Small Stocks, Big Money

12 minutes 1 second

2 months ago

Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe

Aptevo Therapeutics Inc. (Nasdaq: APVO) is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies through its proprietary bispecific antibody platforms, ADAPTIR® and ADAPTIR-FLEX®. The company is advancing a diverse pipeline that includes both clinical and preclinical candidates designed to harness the immune system to target hematologic and solid tumors with greater precision and safety. With a focus on innovation, Aptevo is leveraging modular antibody engineering to address areas of high unmet medical need and capture opportunities across multi-billion-dollar oncology markets.Aptevo Therapeutics is a client of RedChip. Visit APVOinfo.com to learn more.